Micropoint Technologies
Singapore, Singapore· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Micropoint delivers cost‑effective microneedle solutions for transdermal therapeutics and diagnostics, spanning prototyping to pilot‑scale manufacturing.
DermatologyVaccinesDrug Delivery
Technology Platform
Proprietary microneedle manufacturing covering stainless‑steel, plastic injection‑moulded and polymeric dissolving needles, enabling high‑volume, low‑cost transdermal delivery and diagnostic sampling.
Opportunities
Growing demand for needle‑free vaccine delivery and cosmetic microneedle treatments creates a sizable market for Micropoint’s scalable, low‑cost platforms.
Risk Factors
Scaling from pilot to full commercial manufacturing and securing long‑term OEM contracts are critical challenges; regulatory hurdles for new drug‑delivery indications may also delay market entry.
Competitive Landscape
Key competitors include 3M, Zosano Pharma and Valeritas; Micropoint differentiates itself through its end‑to‑end service model, proprietary stainless‑steel moulds, and ability to produce both solid and hollow microneedles at volume.